Exhibit 107
Calculation of Filing Fee Table
S-3
(Form Type)
Acer Therapeutics Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Unit (2) | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||
Fees to be Paid | Equity | Common Stock, $0.0001 par value per share | 457(c) | 2,478,000 (3) | $2.41 | $5,959,590.00 | 0.0000927 | $552.45 | ||||||||
Total Offering Amounts | $5,959,590.00 | |||||||||||||||
Total Fee Offsets | ||||||||||||||||
Net Fee Due | $552.45 |
(1) | Pursuant to Rule 416(a) under the Securities Act of 1933, the registrant is also registering hereunder an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions. |
(2) | Estimated pursuant to Rule 457(c) solely for the purpose of calculating the registration fee, based upon the average of the high and low prices for the registrant’s common stock as reported on the Nasdaq Capital Market on April 14, 2022. |
(3) | Represents shares of the registrant’s common stock issuable upon conversion of the registrant’s secured convertible promissory notes issued in connection with the March 2022 private placement. |